Trinity Biotech (TRIB) Shares Outstanding (Weighted Average) (2009 - 2025)

Trinity Biotech's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $40000.0 for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) fell 99.05% year-over-year to $40000.0; the TTM figure through Dec 2025 stood at $40000.0 (down 99.05% YoY), while the FY2025 annual figure was $40000.0, down 99.05% from the prior year.
• Shares Outstanding (Weighted Average) came in at $40000.0 for Q4 2025 at Trinity Biotech, down from $4.3 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $4.3 billion in Q2 2025 to a low of $40000.0 in Q4 2025.
• A 5-year average of $1.5 billion and a median of $1.7 billion in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 85.5% in 2025 and fell as far as 99.05% in 2025.
• Trinity Biotech's Shares Outstanding (Weighted Average) stood at $83.6 million in 2021, then soared by 61.4% to $134.9 million in 2022, then grew by 13.46% to $153.1 million in 2023, then tumbled by 97.26% to $4.2 million in 2024, then sank by 99.05% to $40000.0 in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $40000.0, $4.3 billion, and $4.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison